Navitoclax

Near Add Your Location

Accepting patients

A Phase Ib/II Study Evaluating Navitoclax After Failure of Hypomethylating Agent and Venetoclax for Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome
Learn more
  • BCL-2 Inhibitor
  • Phase 1/2